LUPIN LIMITED (LUPIN) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Lat…
Lupin Limited
LUPIN
Market Cap₹1,08,547Cr.
Current Price₹2,374
High / Low₹2,530/1,837
Stock P/E18.8
Book Value₹659
Dividend Yield0.76%
ROCE26.2%
ROE21.2%
Face Value₹2.00
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 16:39:46